Sarepta Therapeutics | SRPT - Action





Action Changement Date
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amgen USD 6.19B 39M 2026-03
BioCryst Pharmaceuticals USD 5.98M 587K 2026-03
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Daiichi Sankyo JPY 608.55B 93.64B 2025-09
Eli Lilly USD 14.53B 785M 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
Incyte USD 115.62M 14.56M 2026-03
Insmed USD 132.91M 841K 2026-03
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Moderna USD 146M 7M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
Novavax USD 11.46M 87K 2026-03
Pfizer USD 10.67B 13M 2026-03
PTC Therapeutics USD 75.57M 4.08M 2026-03
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 1B 86.37M 2026-03
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03